GlassScriptPhysician profile
Ellie P Goldbloom
NPI 1437135092
$5,668.66
in general payments reported to CMS, 2019-2025
37 companies · $990 in 2025
The $990 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $259 · 2021: $551 · 2022: $815 · 2023: $1,480 · 2024: $1,260 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,729.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $856.49 | 2021-2025 | |
| Lilly USA, LLC | $794.89 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $679.54 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $523.22 | 2019-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $441.41 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $440.83 | 2019-2025 | |
| Glaxosmithkline, LLC. | $301.04 | 2021-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $218.75 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.95 | 2022-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $113.80 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $110.92 | 2019-2025 | Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $110.65 | 2021-2023 | Trintellix |
| Daiichi Sankyo INC. | $107.24 | 2021-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $97.53 | 2023-2025 | Capvaxive, Dificid, Gardasil 9 |
| Esperion Therapeutics, INC. | $77.27 | 2023-2024 | Nexletol |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $76.88 | 2020-2021 | |
| Allergan, INC. | $75.85 | 2019-2020 | |
| Exact Sciences Corporation | $71.63 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $60.29 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $51.38 | 2023-2024 | Gemtesa |
| Cleerly, INC. | $34.88 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Idorsia Pharmaceuticals US INC | $29.38 | 2023 | Quviviq |
| Neurelis, INC. | $25.59 | 2025 | Valtoco |
| Bausch Health US, LLC | $23.58 | 2022 | |
| Kaleo, INC. | $21.62 | 2021 | |
| Philips North America LLC | $20.98 | 2024 | (Ck6) Holter |
| E.R. Squibb & Sons, L.L.C. | $20.04 | 2025 | Eliquis |
| Abbott Laboratories | $17.43 | 2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $17.18 | 2023 | Nuedexta |
| Biohaven Pharmaceuticals, INC. | $17.18 | 2021 | |
| Horizon Therapeutics Plc | $17.02 | 2022 | |
| Genzyme Corporation | $16.78 | 2024 | |
| 3b Medical, INC. | $16.32 | 2025 | Luna |
| Boston Scientific Corporation | $15.56 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.99 | 2019 | |
| Amarin Pharma, INC. | $12.92 | 2022 | |
| Sanofi Pasteur INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellie Goldbloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.